<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl12888</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-12888</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical endocrinology</subject></subj-group></article-categories><title-group><article-title>Комплексный подход к лечению претибиальной микседемы на основе пульс-терапии преднизолоном и электронейромиостимуляции (FREMS-терапии) у пациентки с болезнью Грейвса и эндокринной офтальмопатией</article-title><trans-title-group xml:lang="en"><trans-title>An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves’ disease and thyroid eye disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5824-6490</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перепелова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Perepelova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перепелова Маргарита Александровна </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11, к. 2</p></bio><bio xml:lang="en"><p> Margarita A. Perepelova </p><p> Dmitry Ulyanov street 11 bld. 2, 117036 Moscow, Russia </p><p> </p></bio><email xlink:type="simple">margo.doktor@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3735-019X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зайцева Екатерина Леонидовна, к.м.н. </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11, к. 2</p></bio><bio xml:lang="en"><p> Ekaterina L. Zaitseva, MD, PhD </p><p> Dmitry Ulyanov street 11 bld. 2, 117036 Moscow, Russia </p></bio><email xlink:type="simple">zai.kate@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5910-6502</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бессмертная</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Bessmertnaya</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бессмертная Елена Григорьевна, к.м.н. </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11, к. 2</p></bio><bio xml:lang="en"><p> Elena G. Bessmertnaya, PhD </p><p> Dmitry Ulyanov street 11 bld. 2, 117036 Moscow, Russia </p></bio><email xlink:type="simple">bessmertnaya.eg@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6461-8243</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Груша</surname><given-names>Я. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Grusha</surname><given-names>Ya. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Груша Ярослав Олегович, д.м.н., профессор </p><p>Москва</p></bio><bio xml:lang="en"><p>Yaroslav O. Grusha, MD, DSc, Professor </p><p>Moscow</p></bio><email xlink:type="simple">grusha-y@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8538-5354</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свириденко</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sviridenko</surname><given-names>N. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Свириденко Наталья Юрьевна, д.м.н., профессор </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11, к. 2</p></bio><bio xml:lang="en"><p> Natalya Yu. Sviridenko, MD, PhD, Professor </p><p> Dmitry Ulyanov street 11 bld. 2, 117036 Moscow, Russia </p></bio><email xlink:type="simple">natsvir@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6581-4521</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галстян</surname><given-names>Г. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Galstyan</surname><given-names>G. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галстян Гагик Радикович, д.м.н., профессор </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11, к. 2</p></bio><bio xml:lang="en"><p> Gagik R. Galstyan, MD, PhD, Professor </p><p> Dmitry Ulyanov street 11 bld. 2, 117036 Moscow, Russia </p></bio><email xlink:type="simple">galstyangagik964@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт глазных болезней им. М.М. Краснова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>30</day><month>08</month><year>2023</year></pub-date><volume>69</volume><issue>4</issue><fpage>32</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Перепелова М.А., Зайцева Е.Л., Бессмертная Е.Г., Груша Я.О., Свириденко Н.Ю., Галстян Г.Р., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Перепелова М.А., Зайцева Е.Л., Бессмертная Е.Г., Груша Я.О., Свириденко Н.Ю., Галстян Г.Р.</copyright-holder><copyright-holder xml:lang="en">Perepelova M.A., Zaitseva E.L., Bessmertnaya E.G., Grusha Y.O., Sviridenko N.Y., Galstyan G.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/12888">https://www.probl-endojournals.ru/jour/article/view/12888</self-uri><abstract><p>Болезнь Грейвса (БГ) относится к актуальным проблемам современной эндокринологии, характеризуется высокой частотой, полисистемным поражением организма, неуклонно прогрессирующим течением, диагностическими сложностями, высокой степенью инвалидизации, нередко — резистентностью к терапии. К проявлениям заболевания относят: синдром тиреотоксикоза c нарушением обмена липидов, углеводов, активацией полиорганной патологии в виде эндокринной офтальмопатии (ЭОП), претибиальной микседемы, сердечно-сосудистой недостаточности, акропатии, поражений нервной, костно-суставной системы, а также другие нарушения. Развитие полиорганной патологии может иметь разную последовательность, разные временные промежутки и разную степень выраженности. Любые разработки в направлении уточнения этиопатогенетических, клинико-диагностических и лечебно-реабилитационных мероприятий представляют несомненную значимость. Нами представлен клинический случай БГ, ЭОП и претибиальной микседемы, при котором был апробирован комплексный подход в тактике лечения претибиальной микседемы (комбинация пульс-терапии преднизолоном и электронейромиостимуляции — FREMS-терапии), в результате которого были получены положительные результаты в течение короткого времени.</p></abstract><trans-abstract xml:lang="en"><p>Graves’ disease (GD) is one of the urgent problems of modern endocrinology, characterized by a high frequency, polysystemic damage to the body, a steadily progressive course, diagnostic difficulties, a high degree of disability and often resistance to therapy. The manifestations of the disease include: thyrotoxicosis syndrome with impaired lipid and carbohydrate metabolism, and activation of multiple organ pathology in the form of thyroid eye disease (TED), pretibial myxedema, cardiovascular insufficiency, acropathy, lesions of the nervous, osteoarticular system, and other lesions. The development of multiple organ pathology can have a different sequence, different time intervals and different degrees of severity. Any developments in the direction of clarifying the etiopathogenetic, clinical diagnostic and treatment-rehabilitation measures are of undoubted significance. We present a clinical case of GD, TED and pretibial myxedema, in which an integrated approach was tested in the tactics of treating pretibial myxedema (a combination of pulse therapy with prednisolone and FREMS-therapy), as a result of which positive results were obtained within a short time.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Грейвса</kwd><kwd>претибиальная микседема</kwd><kwd>эндокринная офтальмопатия</kwd><kwd>электронейромиостимуляция (FREMS-терапия)</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Graves’ disease</kwd><kwd>pretibial myxedema</kwd><kwd>thyroid eye disease</kwd><kwd>electrical neuromyostimulation (FREMS-therapy)</kwd></kwd-group></article-meta></front><back><ref-list><ref id="cit1"><element-citation><name><surname>Bartalena</surname> <given-names>Luigi</given-names> </name> <name><surname>Fatourechi</surname> <given-names>Vahab</given-names> </name> <article-title>Extrathyroidal manifestations of Graves’ disease: a 2014 update</article-title> <source>Journal of Endocrinological Investigation</source> <year>2014</year> <month>06</month> <fpage>691</fpage> <lpage>700</lpage> <volume>37</volume> <issue>8</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/s40618-014-0097-2</object-id></element-citation></ref><ref id="cit2"><element-citation><name><surname>Daumerie</surname> <given-names>C</given-names> </name> <name><surname>Ludgate</surname> <given-names>M</given-names> </name> <name><surname>Costagliola</surname> <given-names>S</given-names> </name> <name><surname>Many</surname> <given-names>MC</given-names> </name> <article-title>Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy</article-title> <source>European Journal of Endocrinology</source> <year>2005</year> <month>01</month> <fpage>35</fpage> <lpage>38</lpage> <object-id pub-id-type="doi" specific-use="metadata">10.1530/eje.0.1460035</object-id></element-citation></ref><ref id="cit3"><element-citation><name><surname>Schwartz</surname> <given-names>Kara M.</given-names> </name> <name><surname>Fatourechi</surname> <given-names>Vahab</given-names> </name> <name><surname>Ahmed</surname> <given-names>Debra D. F.</given-names> </name> <name><surname>Pond</surname> <given-names>Gregory R.</given-names> </name> <article-title>Dermopathy of Graves’ Disease (Pretibial Myxedema): Long-Term Outcome</article-title> <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <year>2014</year> <month>01</month> <fpage>438</fpage> <lpage>446</lpage> <volume>87</volume> <issue>2</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1210/jcem.87.2.8220</object-id></element-citation></ref><ref id="cit4"><element-citation><name><surname>Fatourechi</surname> <given-names>Vahab</given-names> </name> <article-title>Pretibial Myxedema</article-title> <source>American Journal of Clinical Dermatology</source> <year>2006</year> <month>01</month> <fpage>295</fpage> <lpage>309</lpage> <volume>6</volume> <issue>5</issue> <object-id pub-id-type="doi" specific-use="metadata">10.2165/00128071-200506050-00003</object-id></element-citation></ref><ref id="cit5"><element-citation><name><surname>Martinenghi</surname> <given-names>Sabina</given-names> </name> <name><surname>Caretto</surname> <given-names>Amelia</given-names> </name> <name><surname>Losio</surname> <given-names>Claudio</given-names> </name> <name><surname>Scavini</surname> <given-names>Marina</given-names> </name> <name><surname>Bosi</surname> <given-names>Emanuele</given-names> </name> <article-title>Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation</article-title> <source>Medicine</source> <year>2015</year> <month>06</month> <fpage>e950</fpage> <volume>94</volume> <issue>24</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1097/md.0000000000000950</object-id></element-citation></ref><ref id="cit6"><element-citation><name><surname>Bevilacqua</surname> <given-names>M.</given-names> </name> <name><surname>Dominguez</surname> <given-names>L. J.</given-names> </name> <name><surname>Barrella</surname> <given-names>M.</given-names> </name> <name><surname>Barbagallo</surname> <given-names>M.</given-names> </name> <article-title>Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy</article-title> <source>Journal of Endocrinological Investigation</source> <year>2014</year> <month>04</month> <fpage>944</fpage> <lpage>947</lpage> <volume>30</volume> <issue>11</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/bf03349242</object-id></element-citation></ref><ref id="cit7"><element-citation><name><surname>Bosi</surname> <given-names>E.</given-names> </name>  <name><surname>Bax</surname> <given-names>G.</given-names> </name> <name><surname>Scionti</surname> <given-names>L.</given-names> </name> <name><surname>Spallone</surname> <given-names>V.</given-names> </name> <name><surname>Tesfaye</surname> <given-names>S.</given-names> </name> <name><surname>Valensi</surname> <given-names>P.</given-names> </name> <name><surname>Ziegler</surname> <given-names>D.</given-names> </name> <article-title>Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial</article-title> <source>Diabetologia</source> <year>2012</year> <month>12</month> <fpage>467</fpage> <lpage>475</lpage> <volume>56</volume> <issue>3</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/s00125-012-2795-7</object-id></element-citation></ref><ref id="cit8"><element-citation><name><surname>Santamato</surname> <given-names>Andrea</given-names> </name> <name><surname>Panza</surname> <given-names>Francesco</given-names> </name> <name><surname>Fortunato</surname> <given-names>Francesca</given-names> </name> <name><surname>Portincasa</surname> <given-names>Aurelio</given-names> </name> <name><surname>Frisardi</surname> <given-names>Vincenza</given-names> </name> <name><surname>Cassatella</surname> <given-names>Gennaro</given-names> </name> <name><surname>Valente</surname> <given-names>Mauro</given-names> </name> <name><surname>Seripa</surname> <given-names>Davide</given-names> </name> <name><surname>Ranieri</surname> <given-names>Maurizio</given-names> </name> <name><surname>Fiore</surname> <given-names>Pietro</given-names> </name> <article-title>Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults</article-title> <source>Rejuvenation Research</source> <year>2012</year> <month>06</month> <fpage>281</fpage> <lpage>287</lpage> <volume>15</volume> <issue>3</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1089/rej.2011.1236</object-id></element-citation></ref><ref id="cit9"><element-citation><name><surname>Gandolfi</surname> <given-names>Alessandra</given-names> </name> <name><surname>Pontara</surname> <given-names>Andrea</given-names> </name> <name><surname>Di Terlizzi</surname> <given-names>Gaetano</given-names> </name> <name><surname>Rizzo</surname> <given-names>Nathalie</given-names> </name> <name><surname>Nicoletti</surname> <given-names>Roberto</given-names> </name> <name><surname>Scavini</surname> <given-names>Marina</given-names> </name> <name><surname>Galimberti</surname> <given-names>Gabriella</given-names> </name> <name><surname>Bosi</surname> <given-names>Emanuele</given-names> </name> <article-title>Improvement in Clinical Symptoms of Scleredema Diabeticorum by Frequency-Modulated Electromagnetic Neural Stimulation: A Case Report</article-title> <source>Diabetes Care</source> <year>2014</year> <month>10</month> <fpage>e233</fpage> <lpage>e234</lpage> <volume>37</volume> <issue>11</issue> <object-id pub-id-type="doi" specific-use="metadata">10.2337/dc14-0730</object-id></element-citation></ref><ref id="cit10"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Andersson</surname> <given-names>U</given-names></name>, <name><surname>Tracey</surname> <given-names>KJ.</given-names></name> <article-title>A new approach to rheumatoid arthritis: treating inflammation with computerized nerve stimulation.</article-title> <source>Cerebrum.</source> <year>2012</year>;2012:<month>3</month>.</mixed-citation></ref><ref id="cit11"><element-citation><name><surname>Bartalena</surname> <given-names>Luigi</given-names> </name> <name><surname>Baldeschi</surname> <given-names>Lelio</given-names> </name> <name><surname>Boboridis</surname> <given-names>Kostas</given-names> </name> <name><surname>Eckstein</surname> <given-names>Anja</given-names> </name> <name><surname>Kahaly</surname> <given-names>George J.</given-names> </name> <name><surname>Marcocci</surname> <given-names>Claudio</given-names> </name> <name><surname>Perros</surname> <given-names>Petros</given-names> </name> <name><surname>Salvi</surname> <given-names>Mario</given-names> </name> <name><surname>Wiersinga</surname> <given-names>Wilmar M.</given-names> </name>  <article-title>The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy</article-title> <source>European Thyroid Journal</source> <year>2016</year> <month>03</month> <fpage>9</fpage> <lpage>26</lpage> <volume>5</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1159/000443828</object-id></element-citation></ref><ref id="cit12"><element-citation><name><surname>Ismailova</surname> <given-names>Dilyara S</given-names> </name> <name><surname>Belovalova</surname> <given-names>Irina M</given-names> </name> <name><surname>Grusha</surname> <given-names>Yaroslav O</given-names> </name> <name><surname>Sviridenko</surname> <given-names>Natalya Y</given-names> </name> <article-title>Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review</article-title> <source>International Medical Case Reports Journal</source> <year>2018</year> <month>09</month> <fpage>243</fpage> <lpage>249</lpage> <volume>Volume 11</volume> <object-id pub-id-type="doi" specific-use="metadata">10.2147/imcrj.s164372</object-id></element-citation></ref><ref id="cit13"><element-citation><name><surname>Varma</surname> <given-names>Aakaash</given-names> </name> <name><surname>Rheeman</surname> <given-names>Charles</given-names> </name> <name><surname>Levitt</surname> <given-names>Jacob</given-names> </name> <article-title>Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease</article-title> <source>JAAD Case Reports</source> <year>2020</year> <month>09</month> <fpage>1281</fpage> <lpage>1282</lpage> <volume>6</volume> <issue>12</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.jdcr.2020.09.003</object-id></element-citation></ref><ref id="cit14"><element-citation><name><surname>Petit</surname> <given-names>Lauren</given-names> </name> <name><surname>Catinis</surname> <given-names>Anna</given-names> </name> <name><surname>Richard</surname> <given-names>Emily</given-names> </name> <name><surname>Silverberg</surname> <given-names>Joel</given-names> </name> <article-title>A case of pretibial myxedema treated with teprotumumab</article-title> <source>JAAD Case Reports</source> <year>2021</year> <month>09</month> <fpage>134</fpage> <lpage>136</lpage> <volume>16</volume> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.jdcr.2021.08.026</object-id></element-citation></ref><ref id="cit15"><element-citation><name><surname>Engin</surname> <given-names>Burhan</given-names> </name> <name><surname>Gümüşel</surname> <given-names>Munise</given-names> </name> <name><surname>Özdemir</surname> <given-names>Mustafa</given-names> </name> <name><surname>Çakir</surname> <given-names>Mehtap</given-names> </name> <article-title>Successful combined pentoxifylline and intralesional triamcinolone acetonide treatment of severe pretibial myxedema</article-title> <source>Dermatology Online Journal</source> <year>2021</year> <month>06</month> <volume>13</volume> <issue>2</issue> <object-id pub-id-type="doi" specific-use="metadata">10.5070/d38nd2c6tr</object-id></element-citation></ref><ref id="cit16"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Silapunt</surname> <given-names>S</given-names></name>, <name><surname>Agwu</surname> <given-names>AV</given-names></name>, <name><surname>Migden</surname> <given-names>MR.</given-names></name> <article-title>Severe pretibial myxedema refractory to systemic immunosuppressants.</article-title> <source>Cutis.</source> <year>2019</year>;<issue>104(3)</issue>:<fpage>E1</fpage>-<lpage>E3</lpage>.</mixed-citation></ref><ref id="cit17"><element-citation><name><surname>Takasu</surname> <given-names>Nobuyuki</given-names> </name> <name><surname>Higa</surname> <given-names>Haruyo</given-names> </name> <name><surname>Kinjou</surname> <given-names>Yoshino</given-names> </name> <article-title>Treatment of Pretibial Myxedema (PTM) with Topical Steroid Ointment Application with Sealing Cover (Steroid Occlusive Dressing Technique: Steroid ODT) in Graves' Patients</article-title> <source>Internal Medicine</source> <year>2010</year> <month>04</month> <fpage>665</fpage> <lpage>669</lpage> <volume>49</volume> <issue>7</issue> <object-id pub-id-type="doi" specific-use="metadata">10.2169/internalmedicine.49.2617</object-id></element-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
